Results 171 to 180 of about 79,317 (281)
A systematic overview of the first pasteurised VWF/FVIII medicinal product, Haemate®P/ Humate®-P: History and clinical performance [PDF]
Erik Berntorp +11 more
openalex +1 more source
Abstract Objectives We aimed to investigate the quality of platelets after storage following irradiation with ultraviolet C (UVC) light‐emitting diodes (LED). Background Controlling transfusion‐related infections, particularly bacterial contamination of platelet concentrates (PCs), is urgently required. UVC‐LEDs have attracted considerable attention as
Tomoya Hayashi +8 more
wiley +1 more source
Effect of age on ISTH-BAT scores and low VWF diagnosis in the Zimmerman Program. [PDF]
Atiq F +15 more
europepmc +1 more source
Ashwell receptor (Asgr-1 and Asgr-2); von Willebrand factor (vWF); platelets [PDF]
openalex +1 more source
Abstract Background We tested the hypothesis that the addition of biomarkers of multimorbidity and biological aging would improve the predictive accuracy of point‐of‐care viscoelastometry or laboratory tests of coagulation for clinically important bleeding following cardiac surgery.
Weiqi Liao +8 more
wiley +1 more source
ADAM metallopeptidase with thrombospondin type 1 motif 13 (ADAMTS13); von Willebrand factor (VWF) [PDF]
openalex +1 more source
ABSTRACT Background In humans, deficiency of a disintegrin‐like and metalloprotease with thrombospondin type 1 motifs, number 13 (ADAMTS13), a von Willebrand factor (vWF) cleaving protease, is an underlying mechanism for thrombosis. The role of ADAMTS13 in canine thromboembolic disease is largely unknown.
Ashley R. Wilkinson +2 more
wiley +1 more source
Risk assessment of pARDS in severe pneumonia patients based on lung injury prediction scores and serum biomarkers. [PDF]
Qiao J, Feng Y, Cui C, Zou L, Huang X.
europepmc +1 more source

